{
    "organizations": [],
    "uuid": "8607841c4724fe9168de32c1239a66607f6bdbe8",
    "author": "",
    "url": "https://www.reuters.com/article/us-astrazeneca-fasenra/astrazeneca-drug-fasenra-fails-to-achieve-main-goal-in-copd-trial-idUSKCN1IV0M3",
    "ord_in_thread": 0,
    "title": "AstraZeneca drug Fasenra fails to achieve main goal in COPD trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 30, 2018 / 6:51 AM / Updated 8 hours ago AstraZeneca drug Fasenra fails to achieve main goal in COPD trial Reuters Staff 1 Min Read\n(Reuters) - AstraZenecaâ€™s first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD). FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, Britain April 28, 2014. REUTERS/Stefan Wermuth /File Photo\nThe drug is currently approved as an add-on treatment for severe eosinophilic asthma in the United States, the European Union, Japan and several other countries.\nFasenra failed to meet its target in the final-stage trial, named Galathea, this month. Reporting By Justin George Varghese in Bengaluru; Editing by David Goodman",
    "published": "2018-05-30T09:50:00.000+03:00",
    "crawled": "2018-05-30T10:13:30.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "hour",
        "ago",
        "astrazeneca",
        "drug",
        "fasenra",
        "fails",
        "achieve",
        "main",
        "goal",
        "copd",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "reuters",
        "astrazeneca",
        "first",
        "respiratory",
        "biological",
        "medicine",
        "fasenra",
        "failed",
        "meet",
        "main",
        "target",
        "second",
        "clinical",
        "trial",
        "treating",
        "patient",
        "moderate",
        "severe",
        "chronic",
        "obstructive",
        "pulmonary",
        "disease",
        "copd",
        "file",
        "photo",
        "logo",
        "astrazeneca",
        "seen",
        "medication",
        "package",
        "pharmacy",
        "london",
        "britain",
        "april",
        "wermuth",
        "photo",
        "drug",
        "currently",
        "approved",
        "treatment",
        "severe",
        "eosinophilic",
        "asthma",
        "united",
        "state",
        "european",
        "union",
        "japan",
        "several",
        "country",
        "fasenra",
        "failed",
        "meet",
        "target",
        "trial",
        "named",
        "galathea",
        "month",
        "reporting",
        "justin",
        "george",
        "varghese",
        "bengaluru",
        "editing",
        "david",
        "goodman"
    ]
}